» Articles » PMID: 27708229

Prognostic Effect of Intratumoral Neutrophils Across Histological Subtypes of Non-small Cell Lung Cancer

Overview
Journal Oncotarget
Specialty Oncology
Date 2016 Oct 7
PMID 27708229
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Recent data indicate that tumor-associated neutrophils (TANs) serve a dual role in tumor progression and regression. CD66b is a neutrophil marker and has been associated with patient outcome in various cancers. However, its clinical impact in non-small cell lung cancer (NSCLC) remains controversial. 536 NSCLC patients, of which 172 harbored lymph node metastases, were included in this study. Tissue microarrays were constructed and multiplexed immunohistochemistry of CD66b, CD34 and pan-keratin was performed to evaluate the localization and quantity of CD66b+ TANs. High intratumoral CD66b+ TANs density in squamous cell carcinoma (SCC) subgroup was an independent positive prognosticator for disease-specific survival (P = 0.038). In contrast, high intratumoral TANs density was an independent negative prognostic factor in the adenocarcinoma (ADC) subgroup (P= 0.032). Likewise, in ADC patients with lymph node metastases, high level of intratumoral TANs was associated with poor prognosis (P = 0.003). Stromal CD66b+ TANs were not associated with outcome of NSCLC patients. In conclusion, CD66b+ TANs show diverging prognostic effect in NSCLC patients according to histological subgroups. The presence of CD66b+ TANs could prove pivotal for development of an immunoscore in ADC NSCLC patients.

Citing Articles

High density of TCF1+ stem-like tumor-infiltrating lymphocytes is associated with favorable disease-specific survival in NSCLC.

Forde D, Kilvaer T, Pedersen M, Blix E, Urbarova I, Paulsen E Front Immunol. 2025; 15:1504220.

PMID: 39749327 PMC: 11693705. DOI: 10.3389/fimmu.2024.1504220.


Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer.

Enfield K, Colliver E, Lee C, Magness A, Moore D, Sivakumar M Cancer Discov. 2024; 14(6):1018-1047.

PMID: 38581685 PMC: 11145179. DOI: 10.1158/2159-8290.CD-23-1380.


Prognostic value of tumor‑associated CD177 neutrophils in lung adenocarcinoma.

Zhou J, Xu Q, Liu H, Miao J, Bian C, Wei Y Oncol Lett. 2024; 27(5):189.

PMID: 38495836 PMC: 10941067. DOI: 10.3892/ol.2024.14322.


Neutrophil infiltration associated genes on the prognosis and tumor immune microenvironment of lung adenocarcinoma.

Liu R, Zhu G, Sun Y, Li M, Hu Z, Cao P Front Immunol. 2024; 14:1304529.

PMID: 38204755 PMC: 10777728. DOI: 10.3389/fimmu.2023.1304529.


Tumor-associated neutrophils upregulate PANoptosis to foster an immunosuppressive microenvironment of non-small cell lung cancer.

Hu Q, Wang R, Zhang J, Xue Q, Ding B Cancer Immunol Immunother. 2023; 72(12):4293-4308.

PMID: 37907644 PMC: 10992448. DOI: 10.1007/s00262-023-03564-7.


References
1.
Wislez M, Rabbe N, Marchal J, Milleron B, Crestani B, Mayaud C . Hepatocyte growth factor production by neutrophils infiltrating bronchioloalveolar subtype pulmonary adenocarcinoma: role in tumor progression and death. Cancer Res. 2003; 63(6):1405-12. View

2.
Wang J, Jia Y, Wang N, Zhang X, Tan B, Zhang G . The clinical significance of tumor-infiltrating neutrophils and neutrophil-to-CD8+ lymphocyte ratio in patients with resectable esophageal squamous cell carcinoma. J Transl Med. 2014; 12:7. PMC: 3895663. DOI: 10.1186/1479-5876-12-7. View

3.
Yang L, Huang J, Ren X, Gorska A, Chytil A, Aakre M . Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. Cancer Cell. 2008; 13(1):23-35. PMC: 2245859. DOI: 10.1016/j.ccr.2007.12.004. View

4.
Gregory A, Houghton A . Tumor-associated neutrophils: new targets for cancer therapy. Cancer Res. 2011; 71(7):2411-6. DOI: 10.1158/0008-5472.CAN-10-2583. View

5.
Mantovani A . The yin-yang of tumor-associated neutrophils. Cancer Cell. 2009; 16(3):173-4. DOI: 10.1016/j.ccr.2009.08.014. View